Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/54780
Title: Timp1 Promotes Cell Survival by Activating the PDK1 Signaling Pathway in Melanoma
Authors: Toricelli, Mariana [UNIFESP]
Melo, Fabiana H. M. [UNIFESP]
Hunger, Aline
Zanatta, Daniela
Strauss, Bryan E.
Jasiulionis, Miriam G. [UNIFESP]
Keywords: Timp1
anoikis resistance
PI3K pathway
PDK1
PKC
melanoma
Issue Date: 2017
Publisher: Mdpi Ag
Citation: Cancers. Basel, v. 9, n. 4, p. -, 2017.
Abstract: High TIMP1 expression is associated with poor prognosis in melanoma, where it can bind to CD63 and beta 1 integrin, inducing PI3-kinase pathway and cell survival. Phosphatidylinositol (3,4,5)-trisphosphate (PIP3), generated under phosphatidylinositol-3-kinase (PI3K) activation, enables the recruitment and activation of protein kinase B (PKB/AKT) and phosphoinositide-dependent kinase 1 (PDK1) at the membrane, resulting in the phosphorylation of a host of other proteins. Using a melanoma progression model, we evaluated the impact of Timp1 and AKT silencing, as well as PI3K, PDK1, and protein kinase C (PKC) inhibitors on aggressiveness characteristics. Timp1 downregulation resulted in decreased anoikis resistance, clonogenicity, dacarbazine resistance, and in vivo tumor growth and lung colonization. In metastatic cells, pAKT(Thr308) is highly expressed, contributing to anoikis resistance. We showed that PDK1(Ser241) and PKC beta IISer660 are activated by Timp1 in different stages of melanoma progression, contributing to colony formation and anoikis resistance. Moreover, simultaneous inhibition of Timp1 and AKT in metastatic cells resulted in more effective anoikis inhibition. Our findings demonstrate that Timp1 promotes cell survival with the participation of PDK1 and PKC in melanoma. In addition, Timp1 and AKT act synergistically to confer anoikis resistance in advanced tumor stages. This study brings new insights about the mechanisms by which Timp1 promotes cell survival in melanoma, and points to novel perspectives for therapeutic approaches.
URI: https://repositorio.unifesp.br/handle/11600/54780
ISSN: 2072-6694
Other Identifiers: http://dx.doi.org/10.3390/cancers9040037
Appears in Collections:Artigo

Files in This Item:
File SizeFormat 
WOS000404373000011.pdf1.84 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.